Literature DB >> 29655882

Incidence and Mortality of Adults With Pulmonary Hypertension and Congenital Heart Disease.

Sara Søndergaard Schwartz1, Nicolas Madsen2, Henning Bækgaard Laursen3, Russel Hirsch2, Morten Smærup Olsen3.   

Abstract

Reports on pulmonary hypertension (PH) in the aging congenital heart disease (CHD) population are few and focused on arterial PH and patients with systemic-to-pulmonary shunts. Our objective was to estimate incidence and mortality of adult-onset PH in the CHD population. Using Danish nationwide registries, we identified all patients diagnosed with CHD from 1963 to 1974 and 1977 to 2012. Patients were matched 1:10 by birth year and gender with general population subjects. Between 1977 and 2013 adults >18 years of age were followed up until PH diagnosis, death, or emigration, whichever came first, using data from the Danish National Registry of Patients. We computed cumulative incidences of PH. Using Cox regression, we compared the mortality rate between CHD subjects with and without PH matched by gender and birth year. We identified 14,860 patients with CHD. At 70 years of age, their overall cumulative incidence of PH was 7.2% (8.3% in those with systemic-to-pulmonary shunts and 5.3% in those without) compared with 0.4% in the general population. The 1-, 5-, and 10-year mortality for adults with CHD and PH was 24%, 44%, and 52%, respectively. This represented a 4-fold (95% confidence interval 3.3 to 5.6) increase in mortality compared with adults with CHD without PH after adjusting for gender, birth year, CHD severity, and presence of extracardiac defects. In conclusion the incidence of PH was substantially increased in adults with CHD relative to the general population. Of note, the increased incidence was not limited to those with a history of systemic-to-pulmonary shunts. PH was associated with increased mortality.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29655882     DOI: 10.1016/j.amjcard.2018.02.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  ISL1 loss-of-function mutation contributes to congenital heart defects.

Authors:  Lan Ma; Juan Wang; Li Li; Qi Qiao; Ruo-Min Di; Xiu-Mei Li; Ying-Jia Xu; Min Zhang; Ruo-Gu Li; Xing-Biao Qiu; Xun Li; Yi-Qing Yang
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

2.  Residual Pulmonary Hypertension more than 20 Years after Repair of Shunt Lesions.

Authors:  Dovilė Jančauskaitė; Virginija Rudienė; Gabrielius Jakutis; Laurie W Geenen; Jolien W Roos-Hesselink; Lina Gumbienė
Journal:  Medicina (Kaunas)       Date:  2020-06-16       Impact factor: 2.430

3.  Congenital Heart Disease and Risk of Cardiovascular Disease: A Meta-Analysis of Cohort Studies.

Authors:  Tingting Wang; Lizhang Chen; Tubao Yang; Peng Huang; Lesan Wang; Lijuan Zhao; Senmao Zhang; Ziwei Ye; Letao Chen; Zan Zheng; Jiabi Qin
Journal:  J Am Heart Assoc       Date:  2019-05-21       Impact factor: 5.501

4.  Pulmonary Hypertension in Adult Congenital Heart Disease in Asia: A Distinctive Feature of Complex Congenital Heart Disease.

Authors:  Shuenn-Nan Chiu; Chun-Wei Lu; Ming-Tai Lin; Chun-An Chen; Mei-Hwan Wu; Jou-Kou Wang
Journal:  J Am Heart Assoc       Date:  2022-03-14       Impact factor: 6.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.